|
|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
| |
|
Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new
trends and marketing opportunities, as well as highlighting the latest innovations in this
dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.
We're also on Twitter! Follow us @PMPSmag
|
|
|
|
|
|
 |
News and Press Releases |
 |
Klöckner Pentaplast Launches Its 2020 Sustainability Report
London, UK – 19 July 2021 – Klöckner Pentaplast (kp or the
company), a global leader in high barrier protective packaging
solutions, today announced the release of its 2020 Sustainability
Report, detailing its progress and commitment to key sustainability
initiatives. The report provides details of performance relating to
topics that are material to its business and has been prepared in
accordance with the Global Reporting Initiative (GRI) Standards.
More info >> |
|
 |
White Papers |
 |
|
Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody
RSSL
Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >> |
|
|
